Myeloid cells in the era of cancer immunotherapy: Top 3 unanswered questions.

Chaib, Mehdi; Tanveer, Ubaid A; Makowski, Liza

Chaib, Mehdi; Tanveer, Ubaid A; Makowski, Liza.

Afiliação

Chaib M; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Tanveer UA; Division of Hematology Oncology, Department of Medicine, College of Medicine, USA; Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Makowski L; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA; Division of Hematology Oncology, Department of Medicine, College of Medicine, USA; Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Electronic address: liza.makowski@uthsc.edu.

Pharmacol Ther ; 244: 108370, 2023 04.

Article em En | MEDLINE | ID: mdl-36871784

Assuntos

Células Mieloides; Neoplasias; Humanos; Células Mieloides/patologia; Imunoterapia/métodos; Neoplasias/patologia; Imunidade; Microambiente Tumoral

Palavras-chave

Adaptive; Antitumor immunity; Dendritic Cell; Immune checkpoint blockade; Immunosuppression; Innate; MDCS; Macrophage; Myeloid-derived suppressor cells; Tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Mieloides / Neoplasias Limite: Humans Idioma: En Revista: Pharmacol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google